Dublin-Based LearnUpon Secures €44.5 Million Growth Facility for AI-Powered Learning Platform

Irish enterprise‑learning startup LearnUpon raised €44.5 million in growth debt financing from Claret Capital Partners, backed by the Ireland Strategic Investment Fund. The funds will be used to develop its AI‑driven Agentic Learning platform, grow internationally and fund future acquisitions, positioning the company as a leading corporate learning provider in the AI era.

Graham Martin Takes Chairman Role at HomeTruth Following Equity Investment

HomeTruth, a proptech platform that uses AI to help homeowners manage property data, announced that investor Graham Martin has taken an equity stake and will serve as Chairman. Martin, a veteran entrepreneur and former bookmaker executive, will work with co‑founders Monty Munford and Jason Ryan to accelerate product development, partnerships and market expansion.

Cambridge Photonics Firm Salience Labs Raises $125 Million for AI Datacenter Optical Switching Expansion

Salience Labs, a Cambridge‑based developer of photonic chips for AI data‑centre connectivity, secured $125 million in a Series B round led by Bullhound Capital with participation from AMD Ventures, Intel Capital, SBI Group, Hudson River Trading, British Business Bank and existing backers. The funding will be used to scale manufacturing, roll out its optical circuit switching technology, and expand its engineering team and geographic presence.

UK Healthtech Startup Stride Raises £4.6 Million to Expand Preventative Health Platform

UK‑based healthtech startup Stride secured £4.6 million in seed capital from a group of investors including Arāya Ventures and Innovate UK to expand its DNA, blood and gut‑testing based preventative health platform and prepare for international rollout by the end of 2026.

Cambridge RNA Therapeutics Startup Undecimal Bio Raises €16 Million to Expand AI-Powered Delivery Platform

Cambridge‑based spin‑out Undecimal Bio secured €16 million in Seed funding, co‑led by 4BIO Capital and IQ Capital, to develop its AI‑driven DELiveri platform that identifies conjugates for precise siRNA delivery to non‑liver tissues, starting with renovascular diseases.